CXCR2 and familial pancreatic carcinoma: In this work, we engineered a human cell-based NTI-chip that enabled us to decipher the tumor-promoting mechanisms of neutrophils and the tumor-suppressive mechanisms of CXCR2 inhibition as a novel neutrophil-based immunotherapy in pancreatic cancer.